Smoking Cessation and Vascular Health: What Patients Need to Know

Citable definition: Smoking cessation is the clinical process of permanently discontinuing tobacco use, supported where needed by pharmacological and behavioral interventions, with the goal of reducing tobacco-related morbidity and mortality — including the substantial burden of vascular disease attributable to smoking.

Tobacco use is not simply a lifestyle choice. From a vascular medicine perspective, it is one of the most powerful and modifiable risk factors for diseases of the arteries and veins. If you or someone you care for smokes, understanding the vascular consequences — and the evidence-based tools available to quit — may be one of the most important steps toward long-term circulatory health.

This article draws on European vascular medicine literature and validated cessation research to give you a clear, honest picture of what smoking does to your blood vessels, and what stopping it can do for you.

What Does Smoking Do to Your Blood Vessels?

Tobacco smoke is a complex mixture of more than 7,000 chemical compounds. For your vascular system, three categories of harm stand out.

1. Carbon monoxide and tissue hypoxia

Carbon monoxide (CO) — the same colorless gas produced by faulty boilers — is present in tobacco smoke at concentrations that can raise blood CO levels to 5–20% of total hemoglobin capacity (EMC-Vasculaire, Accidents coronariens). This dramatically reduces the oxygen-carrying ability of red blood cells, starving tissues — including arterial walls — of the oxygen they need to function and repair themselves.

2. Nicotine and hemodynamic stress

Nicotine is a potent sympathomimetic agent, meaning it mimics the effects of adrenaline on the nervous system. Each cigarette triggers a direct rise in blood pressure: studies document an average increase of 11 mmHg in systolic blood pressure (SBP) and 9 mmHg in diastolic blood pressure (DBP), sustained for 20 to 40 minutes per cigarette (EMC-Vasculaire, Accidents coronariens). In a pack-a-day smoker, the cardiovascular system is therefore under near-continuous hemodynamic stress.

3. Pro-thrombotic and pro-atherogenic effects

Beyond CO and nicotine, tobacco promotes atherosclerosis (the buildup of fatty plaques inside arterial walls) and increases the tendency of blood to clot. In coronary artery disease, smoking has been shown to double the influence of other cardiovascular risk factors such as high cholesterol and hypertension (EMC-Vasculaire, Accidents coronariens). In peripheral artery disease (PAD — narrowing of the arteries supplying the legs), the link is even more striking: up to 90% of patients with PAD are heavy smokers (EMC-Vasculaire, Accidents coronariens).

These mechanisms explain why vascular surgeons and cardiologists across Europe and North America consistently rank smoking cessation as the single most impactful intervention available to patients with — or at risk of — vascular disease.

The Vascular Diseases Most Linked to Smoking

Smoking does not affect all vessels equally. The conditions most strongly associated with tobacco use include:

• Peripheral artery disease (PAD): narrowing of leg arteries causing pain on walking (claudication) and, in severe cases, critical limb ischemia. The 90% figure above makes PAD arguably the most tobacco-dependent of all vascular diseases.
• Coronary artery disease: heart attacks and angina, where smoking amplifies the risk conferred by other factors.
• Aortic aneurysm: abnormal dilation of the main body artery, strongly promoted by tobacco.
• Stroke: both ischemic (clot-related) and hemorrhagic forms are more common in smokers.
• Deep vein thrombosis (DVT): smoking increases clotting tendency, raising venous thromboembolism risk, particularly in combination with other risk factors such as oral contraceptives.

For a broader overview of arterial conditions, see our arteries section.

Evidence-Based Tools for Smoking Cessation

The good news is that effective, well-studied tools exist to help patients quit. A 2018 French review published in the Revue de Pneumologie Clinique provides a comprehensive overview of validated cessation interventions (Abdul-Kader J et al., Rev Pneumol Clin, 2018; PMID: 29650283).

Nicotine Replacement Therapy (NRT)

NRT — available as patches, gum, lozenges, inhalers, and nasal spray — is the most widely used pharmacological approach to cessation. The core principle is elegant: NRT delivers nicotine to the brain, reducing withdrawal symptoms and cravings, while eliminating exposure to carbon monoxide, tar, and the hundreds of other toxic combustion products in cigarette smoke.

Transdermal patches (worn on the skin for 16 or 24 hours) are particularly relevant for vascular patients because they provide a steady, controlled nicotine release rather than the repeated spikes caused by smoking. While patches do produce measurable hemodynamic effects — the blood pressure rises described above apply to any source of nicotine — these effects are significantly smaller than those of active smoking, and are not accompanied by the CO-mediated hypoxia that makes smoking so damaging to arterial walls.

The 2018 review (PMID: 29650283) confirms NRT as a first-line intervention in tobacco cessation, supported by robust evidence from randomized controlled trials.

Important for vascular patients: NRT, including patches, is generally recommended even in patients with coronary artery disease or PAD. The residual cardiovascular risk from nicotine alone is substantially lower than the ongoing damage caused by continued smoking. Blood pressure monitoring is advisable, particularly in hypertensive patients. Always consult your physician or vascular specialist before starting NRT.

Prescription Medications

Two prescription medications have strong evidence behind them:

• Varenicline (Champix/Chantix): a partial nicotine receptor agonist that reduces both cravings and the pleasure derived from smoking. Considered highly effective in clinical trials.
• Bupropion: originally an antidepressant, it reduces nicotine cravings and withdrawal. Useful in patients where varenicline is contraindicated.

Both are referenced in the 2018 review (PMID: 29650283) as validated pharmacological options alongside NRT.

Behavioral Support

Pharmacotherapy works best when combined with structured behavioral support. This includes:

• Brief physician advice (even a 3-minute conversation significantly increases quit rates)
• Individual or group cognitive-behavioral therapy
• Telephone quit lines
• Digital and app-based support programs

The 2018 review (PMID: 29650283) emphasizes that combining pharmacological and behavioral approaches produces higher long-term abstinence rates than either approach alone.

A Note on E-cigarettes

Electronic cigarettes (vaping devices) are sometimes used as cessation aids. The evidence base is evolving and remains less robust than for NRT or prescription medications. European and American guidelines differ in their recommendations. Our editorial board recommends discussing this option explicitly with your vascular specialist, as the long-term vascular effects of e-cigarette aerosols are not yet fully characterized.

Smoking Cessation in High-Risk Vascular Patients: A Comparison

Prevention: Protecting Your Vascular System Before and After Quitting

Quitting smoking is the most powerful step, but a vascular-protective lifestyle amplifies the benefit:

• Physical activity: regular walking — even 30 minutes daily — improves peripheral circulation and helps manage withdrawal symptoms.
• Diet: a Mediterranean-style diet rich in vegetables, olive oil, fish, and legumes supports arterial health and reduces systemic inflammation.
• Hydration: adequate water intake supports healthy blood viscosity.
• Avoid passive smoke: secondhand smoke carries many of the same vascular risks as active smoking.
• Manage other risk factors: blood pressure, cholesterol, and blood sugar should be monitored and controlled, particularly as nicotine withdrawal can temporarily alter metabolic parameters.

For more on vascular-protective lifestyle habits, visit our prevention section.

When to See a Doctor

Seek prompt medical advice if you are a smoker and experience any of the following:

• Leg pain on walking that relieves with rest (possible claudication — a hallmark of PAD)
• Cold, pale, or bluish feet or toes
• Non-healing wounds on the feet or legs
• Chest pain or tightness, particularly on exertion
• Sudden weakness, numbness, or speech difficulty (possible stroke — call emergency services immediately)
• A pulsating mass in the abdomen (possible aortic aneurysm — urgent evaluation required)

If you are ready to quit smoking and have a history of vascular disease, ask your GP or vascular specialist for a structured cessation plan. Cessation support is increasingly integrated into vascular surgery follow-up across Europe.

Also available in French

For more on vein and artery conditions linked to smoking, explore our veins section and treatments section.

Sources

1. Abdul-Kader J, Airagnes G, D’Almeida S, Limosin F, Le Faou AL. Interventions pour le sevrage tabagique en 2018 [Interventions for smoking cessation in 2018]. Revue de Pneumologie Clinique. 2018 Jun;74(3):160–169. doi: 10.1016/j.pneumo.2018.03.004. PMID: 29650283.

2. Accidents coronariens et tabagisme. EMC-Vasculaire (Encyclopédie Médico-Chirurgicale). [No PMID — institutional reference]. Data cited: hemodynamic effects of nicotine (SBP +11 mmHg, DBP +9 mmHg, 20–40 min duration); CO levels in tobacco smoke (5–20%); 90% prevalence of heavy smoking in PAD patients; doubling of coronary risk by smoking in combination with other risk factors.

Medical Disclaimer

This article is produced by the Petit Veinard Editorial Board for informational and educational purposes only. It does not constitute medical advice, diagnosis, or a prescription. All medical decisions — including starting, stopping, or modifying any cessation treatment — should be made in consultation with a qualified physician or vascular specialist familiar with your personal medical history. If you are experiencing symptoms of a vascular emergency (chest pain, stroke symptoms, acute limb ischemia), call your national emergency number immediately. Petit Veinard is an independent publication and has no commercial relationship with any pharmaceutical manufacturer.